TaiRx, Inc. (TPEX:6580)
Taiwan · Delayed Price · Currency is TWD 14.10
-0.10 (-0.70%)
Jun 18, 2026, 2:00 PM CST
TaiRx Market Cap
TaiRx has a market cap or net worth of 1.58 billion as of June 18, 2026. Its market cap has decreased by -41.71% in one year.
Market Cap
1.58B
Enterprise Value
1.25B
Revenue
27.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.10
Market Cap Chart
Since June 20, 2017, TaiRx's market cap has decreased from 3.25B to 1.58B, a decrease of -51.37%. That is a compound annual growth rate of -7.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 1.58B | -34.78% |
| Dec 31, 2025 | 2.42B | -15.03% |
| Dec 31, 2024 | 2.85B | 17.14% |
| Dec 29, 2023 | 2.44B | -27.90% |
| Dec 30, 2022 | 3.38B | -29.76% |
| Dec 30, 2021 | 4.81B | 86.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sunny Pharmtech | 1.96B |
| 3D Global Biotech | 1.89B |
| Greenyn Biotechnology | 1.82B |
| Synbio Tech | 1.73B |
| Great Novel Therapeutics Biotech & Medicals | 1.72B |
| Anti-Microbial Savior BioteQ | 1.55B |
| Advagene Biopharma | 1.49B |
| NeoCore Technology | 1.46B |